Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

6 min read
admin
October 18, 2025
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through...